Cipralex (escitalopram)

DRUG2 trials

Sponsors

Finnish Institute for Health and Welfare, Medical University of Vienna

Conditions

AlcoholismDepressionMajor Depressive Disorder (MDD)

Phase 4

Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.

CompletedNCT00368862

Finnish Institute for Health and WelfareAlcoholism, Depression

Start: 2005-12-31End: 2006-06-30Target: 80Updated: 2006-08-29

Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People

RecruitingNCT06675851

Medical University of ViennaMajor Depressive Disorder (MDD)

Start: 2022-12-01End: 2026-12-31Target: 120Updated: 2024-11-05

Related Papers

Test-Retest Reliability of Dopaminergic fPET and fMRI Measures During Reward Processing.

2026-06-09

Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.

2008-03-0179 citations